Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study
Background: Major depressive disorder (MDD) not responding to antidepressant treatment poses challenges in planning therapy and prognostic uncertainties. Adjunctive treatment to antidepressants with cognitivebehavioral therapy (CBT) may be useful for these patients. Objective: Determine the efficacy...
Saved in:
Main Authors: | Maneeton N., Thongkam A., Maneeton B. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-77951904768&partnerID=40&md5=01161cab9601e96cec864028d1fb1682 http://www.ncbi.nlm.nih.gov/pubmed/20420109 http://cmuir.cmu.ac.th/handle/6653943832/2608 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study
by: Narong Maneeton, et al.
Published: (2018) -
Fluoxetine in acute treatment of children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis
by: Narong Maneeton, et al.
Published: (2020) -
Fluoxetine in acute treatment of children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis
by: Narong Maneeton, et al.
Published: (2020) -
The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: A pharmacoeconomic evaluation
by: Ronnachai Kongsakon, et al.
Published: (2018) -
Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder
by: Garlow, S.J., et al.
Published: (2014)